Format

Send to

Choose Destination
J Clin Med. 2018 Dec 3;7(12). pii: E511. doi: 10.3390/jcm7120511.

The Emerging Role of Neutrophil Granulocytes in Multiple Sclerosis.

Author information

1
The John Curtin School of Medical Research, The Australian National University, Canberra 2600, Australia. Tonia.Woodberry@anu.edu.au.
2
The John Curtin School of Medical Research, The Australian National University, Canberra 2600, Australia. Sophie.Bouffler@anu.edu.au.
3
The John Curtin School of Medical Research, The Australian National University, Canberra 2600, Australia. Alicia.Wilson@anu.edu.au.
4
The John Curtin School of Medical Research, The Australian National University, Canberra 2600, Australia. Rebecca.Buckland@anu.edu.au.
5
The John Curtin School of Medical Research, The Australian National University, Canberra 2600, Australia. Anne.Bruestle@anu.edu.au.

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system with a strong autoimmune, neurodegenerative, and neuroinflammatory component. Most of the common disease modifying treatments (DMTs) for MS modulate the immune response targeting disease associated T and B cells and while none directly target neutrophils, several DMTs do impact their abundance or function. The role of neutrophils in MS remains unknown and research is ongoing to better understand the phenotype, function, and contribution of neutrophils to both disease onset and stage of disease. Here we summarize the current state of knowledge of neutrophils and their function in MS, including in the rodent based MS model, and we discuss the potential effects of current treatments on these functions. We propose that neutrophils are likely to participate in MS pathogenesis and their abundance and function warrant monitoring in MS.

KEYWORDS:

EAE; NETs; multiple sclerosis; neutrophils; treatment

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center